Tracleer bosentan: ATLN completed enrollment in a 122-patient North American and EU pivotal trial of Tracleer in patients with digital ulcers, a complication of

Actelion Ltd. (SWX:ATLN), Allschwil, Switzerland Product: Tracleer bosentan ( Ro 47-0203) Business: Cardiovascular Therapeutic category: Receptor antagonist Target: Endothelin receptors A and B Descr...